Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 257.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.197%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 257.00
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Spire Heathcare Group Plc

8 Jul 2021 12:26

Samson Rock Capital LLP - Form 8.3 - Spire Heathcare Group Plc

Samson Rock Capital LLP - Form 8.3 - Spire Heathcare Group Plc

PR Newswire

London, July 8

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:SAMSON ROCK CAPITAL LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeSPIRE HEALTHCARE GROUP PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure07/07/2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:ORDINARY 1p
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives:397,9580.10
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 397,9580.10

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
1p ORDINARYEQUITY SWAPREDUCING A LONG POSITION300,000227 GBp
1p ORDINARYEQUITY SWAPREDUCING A LONG POSITION1,750,000230 GBp
1p ORDINARYEQUITY SWAPREDUCING A LONG POSITION3,000,000231 GBp
1p ORDINARYEQUITY SWAPREDUCING A LONG POSITION300,000232 GBp

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:08/07/2021
Contact name:Trishawna Simpson
Telephone number*:02039941800

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
27th May 20211:30 pmRNSForm 8.3 - Spire Healthcare Group plc
27th May 20211:12 pmRNSForm 8.3 - Spire Healthcare Group Plc
27th May 20211:04 pmRNSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
27th May 202111:19 amRNSForm 8.3 - Spire Healthcare Group plc
27th May 202110:31 amRNSForm 8.5 (EPT/RI) - Spire Healthcare Group plc
27th May 202110:09 amRNSForm 8.5 (EPT/RI)-Spire Healthcare Group plc
27th May 20219:53 amRNSForm 8.5 (EPT/RI)
27th May 20219:43 amPRNForm 8.3 - Spire Healthcare Group Plc
27th May 20219:07 amBUSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
26th May 20214:00 pmPRNForm 8.3 - Spire Healthcare Group plc
26th May 20213:28 pmRNSForm 8.3 - Spire Healthcare Group Plc
26th May 202112:47 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
26th May 20217:22 amRNSRecommended Offer for Spire Healthcare Group plc
13th May 20214:42 pmRNSChanges to committee memberships
13th May 20214:28 pmRNSResult of AGM
13th May 20217:00 amRNSAGM STATEMENT
4th May 202110:50 amRNSTotal Voting Rights
21st Apr 20218:48 amRNSHolding(s) in Company
6th Apr 20212:22 pmRNS2020 Annual Report and 2021 Notice of AGM
1st Apr 202111:28 amRNSTotal Voting Rights
19th Mar 20214:36 pmRNSReplacement - Director/PDMR Shareholding
18th Mar 20213:31 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSDirectorate announcement
4th Mar 20217:00 amRNSFinal Results
1st Feb 20212:27 pmRNSTotal Voting Rights
7th Jan 202110:55 amRNSBlock listing application
22nd Dec 20204:45 pmRNSDirector Declaration
21st Dec 20202:42 pmRNSNHS England contract update and trading update
8th Dec 20202:15 pmRNSNHS England contract update
17th Sep 20207:00 amRNSDirectorate announcement
17th Sep 20207:00 amRNSHalf-year Report
13th Aug 20207:00 amRNSNHS contract variation and trading update
1st Jul 20207:10 amRNSCMA investigation concluded
26th Jun 20209:30 amRNSAppointment of Professor Clifford Shearman
14th May 20202:04 pmRNSmembership of Nomination Committee
14th May 202012:51 pmRNSResult of AGM
14th May 20207:00 amRNSAGM Statement
27th Apr 20204:40 pmRNSHolding(s) in Company
9th Apr 20204:05 pmRNSAgreement signed with the NHS Scotland
8th Apr 20203:44 pmRNSHolding(s) in Company
6th Apr 20204:45 pmRNSDirector/PDMR Shareholding
6th Apr 20202:33 pmRNSAnnual Report and Notice of Annual General Meeting
6th Apr 20201:08 pmRNSHeads of Terms signed with the NHS in Wales
6th Apr 20209:00 amRNSDirector/PDMR Shareholding
1st Apr 20207:00 amRNSCovenant waiver agreed with lenders
23rd Mar 20207:00 amRNSStatement re Agreement with NHS England
19th Mar 20204:21 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNext steps on NHS response to COVID-19
13th Mar 20207:00 amRNSNHS COVID-19 support
5th Mar 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.